Vir Biotechnology develops product candidates for serious infectious diseases and cancer. It last closed at $9.25 on Nov 17, down 3.44% on the day. The average 12-month price target from 4 analysts is $24.75 (+167.6% from the last close), with a high of $28.00 and a low of $22.00. Analyst consensus is Strong Buy, based on the latest ratings from 4 firms (4 buy, 0 hold, 0 sell). In the past 30 days there were 1 dark pool print totaling $435K, the largest $435K.
Each firm's latest rating on VIR in the past 90 days
Average 12-month target
$24.75
▲ 167.6% upside
Based on 4 analysts who set a price target on VIR in the past 90 days. The average target is $24.75, with a high of $28.00 and a low of $22.00, compared with the last close of $9.25.
Low $22.00Avg $24.75High $28.00
Blue marker: last close $9.25
Highest target$28.00
Average target$24.75
Lowest target$22.00
Latest rating changes
Morgan StanleyTarget raised
Nov 10Buy$27 → $28
Evercore ISI GroupMaintained
Nov 10Buy$25
NeedhamTarget raised
Nov 10Buy$20 → $24
NeedhamMaintained
Nov 5Buy$20
HC Wainwright & Co.Maintained
Oct 7Buy$22
Date
Firm
Action
Rating
Price target
Nov 10
Morgan Stanley
Target raised
Buy
$27 → $28
Nov 10
Evercore ISI Group
Maintained
Buy
$25
Nov 10
Needham
Target raised
Buy
$20 → $24
Nov 5
Needham
Maintained
Buy
$20
Oct 7
HC Wainwright & Co.
Maintained
Buy
$22
Loading…
Technical Analysis
VIR · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend, nearing oversold
The stock is 23% below its 20 day and 20% below its 50 day average. It is 6% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 37), near oversold. The nearest support is the swing low (Jul 20) at $9.11, and the nearest resistance the Pivot at $9.34.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 9.4%/day
Key levels
$14.3752 week high+55.4%
$11.3620 day average+22.8%
$11.0750 day average+19.7%
$10.42100 day average+12.6%
$9.78200 day average+5.7%
$9.70Swing high (Aug 6)+4.9%
$9.66Pivot R1+4.4%
$9.34Pivot+1.0%
$9.25Last close
$9.11Swing low (Jul 20)−1.5%
$8.94Pivot S1−3.4%
$5.3252 week low−42.5%
Indicators
RSI (14)
37.08
Weak, oversold below 30
Neutral
MACD
-0.10
Below its signal line
Bearish
Stochastic
3.2
Near the bottom of its range
Oversold
ADX (14)
23.7
Weak trend
Williams %R
-95.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-160.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−17.6%
Change over 10 sessions
Bearish
ATR (14)
$0.87
Typical daily range, 9.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Moving sideways
Short trendNeutral
Long trendNot enough history
MomentumFading
StretchNormal
VolatilityHigh, 15.6%/day
Key levels
$14.3752 week high+55.4%
$11.3620 day average+22.8%
$11.0750 day average+19.7%
$10.42100 day average+12.6%
$9.78200 day average+5.7%
$9.70Swing high (Aug 6)+4.9%
$9.66Pivot R1+4.4%
$9.34Pivot+1.0%
$9.25Last close
$9.11Swing low (Jul 20)−1.5%
$8.94Pivot S1−3.4%
$5.3252 week low−42.5%
Indicators
RSI (14)
45.77
Middle of its range
Neutral
MACD
0.41
Below its signal line
Bearish
Stochastic
39.8
Middle of its range
Neutral
ADX (14)
37.3
Trending up
Williams %R
-95.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-72.7
Oversold below −100, overbought above 100
Neutral
Rate of change
−12.9%
Change over 10 sessions
Bearish
ATR (14)
$1.44
Typical daily range, 15.6% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200–
What happened before, for VIR
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how VIR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow VIR usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How VIR has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VIR is in one of them and how their past VIR trades turned out.
Vir Biotechnology is a biotechnology company based in San Francisco, California. It is developing product candidates, none yet approved, for serious infectious diseases and cancer, built on several technology platforms. The company also works with other drugmakers through collaboration and licensing agreements, both acquiring rights to some candidates and granting rights to others for further development.